A new model predicts severe heart failure in patients with laminopathies
A landmark study published in the European Heart Journal has developed the first risk prediction model for severe heart failure events in adults with laminopathies, genetic conditions caused by LMNA gene variants that carry a high risk of dilated cardiomyopathy. The model, derived from a large French registry and validated internationally, identifies four key independent predictors of HF-major adverse cardiac events (HF-MACE), defined as heart failure hospitalization, HF-related death, mechanical circulatory support, or heart transplantation. These predictors are male sex, left ventricular ejection fraction (LVEF) below 50%, specific missense genetic variants, and the presence of a complete left bundle branch block. The model demonstrated strong predictive accuracy, stratifying patients into distinct risk groups with 5-year HF-MACE incidences ranging from 1.5% for those with no risk factors to 22.0% for those with two or more.
Study Significance: For critical care and cardiology specialists managing complex genetic cardiomyopathies, this model provides a crucial tool for early risk stratification and proactive intervention. It enables clinicians to identify high-risk patients with laminopathies before severe decompensation, potentially guiding more aggressive monitoring, timely initiation of advanced heart failure therapies, and earlier referral for mechanical circulatory support or transplantation evaluation. This data-driven approach moves the management of these patients from reactive crisis care towards a preventive, precision medicine strategy, directly impacting clinical decision-making and resource allocation in intensive care and advanced heart failure units.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
